Carcinogenesis, Teratogenesis & Mutagenesis ›› 2016, Vol. 28 ›› Issue (3): 185-189.doi: 10.3969/j.issn.1004-616x.2016.03.005

Previous Articles     Next Articles

Induction of LncRNA PCA3 by glycidyl methacrylate in malignant transformed 16HBE cells and its significance

LIU Hongmei1,2, WANG Quankai1,2, XIE Guangyun1,2, WEN Yanan1, XU Jianning1,2   

  1. 1. National Institute of Occupational Health and Poison Control, Chinese Center for Disease Control and Prevention, Beijing 100050;
    2. Key Laboratory of Chemical Safety and Health, Chinese Center for Disease Control and Prevention, Beijing 100050, China
  • Received:2016-02-02 Revised:2016-03-17 Online:2016-05-31 Published:2016-05-31

Abstract: OBJECTIVE:To investigate the induction of expression of long non-coding RNA PCA3(LncRNA PCA3) by glycidyl methacrylate (GMA) in malignantly transformed 16HBE cells. METHODS:Malignantly trans-formed 16HBE cells (treated with 8 μg/mL GMA) and solvent control cells (DMSO) of the 30th generations were harvested. High throughput LncRNA microarray was used to detect differences in expression profile of LncRNAs among the two groups of cells. Changes in LncRNAs were screened through strategies such as fold change and neighboring genes analysis. Real-time fluorescence quantitative PCR (qPCR) and gene chip were applied to measure the expression levels of LncRNA PCA3 and PRUNE2, respectively. RESULTS:Based on the result of LncRNA microarrays, LncRNA PCA3 in GMA-treated cells was up-regulated by 7.17 folds while PRUNE2 was down-regulated by 2.54 folds. QPCR showed that the expression of LncRNA PCA3[(2.67±0.63)×10-5] in GMA-treated cells was significantly higher than that in the solvent control cells[(1.36±0.44)×10-5] (P<0.05). On the other hand, the gene chip analyses showed that expression of PRUNE2(10.95) was reduced compared to the solvent control cells(19.46). CONCLUSION:LncRNA PCA3 expression can be considered as one of the stable and specific biomarkers involved in GMA- malignant transformation of 16HBE cells.

Key words: glycidyl methacrylate, human bronchial epithelial cells, LncRNA PCA3, PRUNE2

CLC Number: